Canadian company develops foot sensor to monitor diabetic ulcers | Study: Advanced robotics allow prosthetic legs more natural movement | Scientist invents breath-analysis device to measure blood-glucose levels
Web Version
November 14, 2013
AOPA In Advance SmartBrief
News for Professionals in the Orthotics, Prosthetics and Pedorthics Profession

Top StorySponsored By
Canadian company develops foot sensor to monitor diabetic ulcers
Orpyx Medical Technologies of Calgary, Alberta, has developed a wireless shoe insert that collects data on how diabetes patients exert pressure on their feet to help prevent ulcers that can lead to infection or even amputation. The SurroSense Rx system consists of a sensor insert, a wireless "shoe pod" data unit, a smart watch and access to an online tracking site. The device is available to U.S. consumers only through online sales. (11/13)
Share: LinkedIn Twitter Facebook Google+ Email
SureStep is now an Official Distributor of KiddieGAIT & KiddieROCKER
The SureStep SMO and Allard Kiddie product line have always made a great orthotic combination, so it only makes sense to offer them together. Because of our partnership, SureStep customers can easily order both product lines at one convenient time. Give us a call to discuss our competitive pricing.
Science and TechnologySponsored By
Study: Advanced robotics allow prosthetic legs more natural movement
A study published in the journal Science Translational Medicine finds that combined technological advances in robotics, computerization, batteries and electric motors are leading to a new generation of prosthetic legs that can duplicate natural movement when users are negotiating stairs and uneven ground. Studies show that powered lower-limb prostheses are more efficient and wearers have fewer falls linked to hospitalization. These new prosthetic limbs connect in noninvasive and invasive ways, from sensors attached to muscles to electrodes implanted in the brain. Science World Report (11/11)
Share: LinkedIn Twitter Facebook Google+ Email
Scientist invents breath-analysis device to measure blood-glucose levels
A device that analyzes the breath of patients with diabetes can measure blood-glucose levels, according to research presented at the annual meeting of the American Association of Pharmaceutical Scientists. Polymers in the device react to acetone, indicating how much glucose is in the blood. Inventor Ronny Priefer said testing in a controlled setting could happen late next year, with tests of the tool in an uncontrolled setting coming in two years. Medical News Today (11/13)
Share: LinkedIn Twitter Facebook Google+ Email
Tired of biased news stories? Try 1440.
The 1440 Daily Digest provides impartial, comprehensive news to your inbox every morning by scouring 100+ new sources—so you don't have to. Culture, science, sports, politics, business, and more - all in a 5-minute read. Subscribe for free!
Medical News
Worldwide diabetes rates hit new record, expected to grow further
Worldwide diabetes cases hit a new record at 382 million in 2013, compared with 371 million cases last year, according to the latest estimate by the International Diabetes Federation. Researchers also said the number of people living with diabetes may rise to 592 million by 2035. The disease accounts for $548 billion in annual health care spending, and that figure is likely to reach $627 billion by 2035, researchers said. Reuters (11/13)
Share: LinkedIn Twitter Facebook Google+ Email
Topically applied glaucoma drug might help heal chronic wounds
Chronic wounds in five patients that did not respond to conventional therapy responded to topical 0.5% timolol solution, a beta-adrenergic receptor antagonist used to treat glaucoma, researchers reported in JAMA Dermatology. Three wounds healed completely and two were reduced. Medscape (free registration)/Reuters (11/8)
Share: LinkedIn Twitter Facebook Google+ Email
Treatment for acute limb ischemia gets orphan drug status
Mast Therapeutics has received FDA orphan drug status for MST-188, an experimental drug for acute limb ischemia, a rare disease that restricts blood flow to the limbs. The company has also announced its plan to start a phase II clinical proof-of-concept study early next year. Drug Store News (11/13)
Share: LinkedIn Twitter Facebook Google+ Email
Government-rebel impasse delays polio immunization in Sudan
A plan to vaccinate 165,000 children in Sudan against polio has been held up by the failure of a final agreement between the government and the rebel Sudan People's Liberation Movement-North. The rebel group has demanded a final meeting, even though U.N. authorities contend that none is needed. U.N. representative John Ging said that, with a final agreement, the children in the affected region of South Kordofan and Blue Nile could be vaccinated in just four days. Reuters (11/11)
Share: LinkedIn Twitter Facebook Google+ Email
Legislative and Regulatory
CMS urges customers to return, re-enroll at
The CMS on Tuesday started e-mailing notices to approximately 275,000 people who could not complete the enrollment process in's initial launch, inviting them to return and sign up for insurance at the website. CMS Director of Communications Julie Bataille touted "dozens" of fixes to the application process over the weekend, including enhancements to the "834" files that insurers receive from the federal insurance exchange. The CMS cited other corrected issues involving the application process for brokers and agents, a rounding error with premium tax credits and the mistaken cancellation notices sent to insurers. Politico (Washington, D.C.) (11/12), The Hill/Healthwatch blog (11/12), Modern Healthcare (free registration) (11/12)
Share: LinkedIn Twitter Facebook Google+ Email
Business Tips and Advice
Sponsored Content from American Express
Trend Watch
Text messages boost patients' medication adherence, control of diabetes
A study in the Annals of Emergency Medicine found that automated daily text messages boost diabetes patients' medication adherence and control of their condition. Researchers found that self-reported medication adherence among participants who were treated in the emergency department improved to 5.4 from 4.5 on an eight-point scale, while participants' blood glucose levels were reduced by 1.05% after they received text messages for six months. Healthcare Informatics online (11/11)
Share: LinkedIn Twitter Facebook Google+ Email
Breaking news from AOPA
AOPA reaffirms support for the Convention on the Rights for Persons with Disabilities – send a letter to your senator today! The 2014 AOPAversity Audio Conference topics and dates have been announced – mark your calendars! Become a presenter at the 2014 AOPA National Assembly – the place to be! Speaking of the Assembly, attention to all 2013 O&P World Congress Exhibitors: There is still exclusive exhibit space at the 2014 Assembly for you – act now! The AOPA Bookstore has released the 2013 Operating Performance Report and 2013 Compensation & Benefits Report – get your reports today! All of this and more in today’s AOPA Breaking News.
Share: LinkedIn Twitter Facebook Google+ Email
Upcoming events
Dec. 11: What's on the Horizon: New Codes for 2014 (Telephone audio conference)
Register online
Share: LinkedIn Twitter Facebook Google+ Email
Here is the test to find whether your mission on Earth is finished: if you're alive, it isn't."
-- Richard Bach,
American writer
Share: LinkedIn Twitter Facebook Google+ Email
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Lead Editor:  Lisa Gough
Account Director:  Aaron Kern
  P: 202.407.7866

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.®
Privacy policy |  Legal Information